Selected Publications

Farber MB and Shah A: The FDA is at a crossroads for reducing tobacco-related disease and death. STAT 2022.

Kadakia KT, Pazdur R, Shah A: US Food and Drug Administration support for oncology drug development during COVID-19. JAMA Oncol 2021.

Shah A: Medicare needs to OK rule giving seniors access to FDA-approved medical devices. CNBC 2021.

Kadakia KT and Shah A: Addressing antimicrobial resistance – the invisible pandemic. Health Affairs Forefront 2021.

Shah A and Hahn S: The FDA response to COVID-19 at six months: regulatory innovation in the face of a pandemic. Health Affairs Forefront 2020.

Shah A, Marks P, Hahn S: Ensuring the safety and effectiveness of a COVID-19 vaccine. Health Affairs Forefront 2020.

Hahn S and Shah A: The coronavirus pandemic underscores the need to bring drug manufacturing back to the U.S. CNBC 2020.

Shah A, Marks PW, Hahn SM: Unwavering regulatory safeguards for COVID-19 vaccines. JAMA: Journal of the American Medical Association 2020.

Shah A, Kadakia KT, Marks P, Cavazzoni P, Hahn S: FDA initiatives to accelerate the development of COVID-19 therapeutics. Health Affairs Forefront 2020.

Shah A, Shuren J, Hahn S: FDA support for expedited access to COVID-19 diagnostics. Health Affairs Forefront 2020.